Published on 26 Oct 2021 on Insider Monkey via Yahoo Finance

Hedge Funds Are Warming Up To Beam Therapeutics Inc. (BEAM)

In this article we will analyze whether Beam Therapeutics Inc. (NASDAQ:BEAM) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There's no better way to get these firms' immense resources and analytical capabilities working for us than to follow their lead into their best ideas. While not all of these picks will be winners, our research shows that these picks historically outperformed the market by double digits annually.

Is Beam Therapeutics Inc. (NASDAQ:BEAM) an exceptional investment today? Hedge funds were becoming hopeful. The number of bullish hedge fund bets moved up by 3 in recent months. Beam Therapeutics Inc. (NASDAQ:BEAM) was in 21 hedge funds' portfolios at the end of the second quarter of 2021. The all time high for this statistic was previously 18. This means the bullish number of hedge fund positions in this stock currently sits at its all time high. Our calculations also showed that BEAM isn't among the 30 most popular stocks among hedge funds (click for Q2 rankings).

So, why do we pay attention to hedge fund sentiment before making any investment decisions? Our research has shown that hedge funds' small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by more than 79 percentage points since March 2017 (see the details here). We have been able to outperform the passive index funds by tracking the moves of corporate insiders and hedge funds, and we believe small investors can benefit a lot from reading hedge fund investor letters and 13F filings.